Details
Stereochemistry | ACHIRAL |
Molecular Formula | Ti |
Molecular Weight | 47.867 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Ti]
InChI
InChIKey=RTAQQCXQSZGOHL-UHFFFAOYSA-N
InChI=1S/Ti
DescriptionCurator's Comment: description was created based on several sources, including
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/022009s000_ClinPharmR.pdf | https://www.ncbi.nlm.nih.gov/pubmed/18503414
Curator's Comment: description was created based on several sources, including
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/022009s000_ClinPharmR.pdf | https://www.ncbi.nlm.nih.gov/pubmed/18503414
Titanium dioxide, also known as titanium(IV) oxide or titania, is the naturally occurring oxide of titanium, chemical formula TiO
2. When used as a pigment, it is called titanium white, Pigment White 6 (PW6), or CI 77891. Generally it is sourced from ilmenite, rutile and anatase. It has a wide range of applications, from paint to sunscreen to food coloring. When used as a food coloring, it has E number E171. World production in 2014 exceeded 9 million metric tons. Titanium dioxide has excellent ultraviolet (UV) resistant qualities and acts as a UV absorbent. In the pharmaceutical industry, titanium dioxide is used in most sunscreens to block UVA and UVB rays, similar to zinc oxide. It is also commonly used as pigment for pharmaceutical products such as gelatin capsules, tablet coatings and syrups. In the cosmetics industry, it is used in toothpaste, lipsticks, creams, ointments and powders. It can be used as an opacifier to make pigments opaque. The FDA has approved the safety of titanium dioxide for use as a colorant in food, drugs and cosmetics, including sunscreens. However, controversy exists as to the safety of titanium dioxide nanoparticles used in the cosmetics industry, for example in sunscreens. Titanium and zinc oxides may be made into the nanoparticle size (0.2-100 nanometers) to reduce the white appearance when applied topically, but retain the UV blocking properties. Recent studies suggest titanium dioxide nanoparticles may be toxic, although further research is needed.
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/18503414
Curator's Comment: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/022009s000_ClinPharmR.pdf
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: ultraviolet induced damage Sources: https://www.ncbi.nlm.nih.gov/pubmed/18503257 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Preventing | ANTHELIOS 40 Approved UseUnknown Launch Date2008 |
|||
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Increased expression of manganese-containing superoxide dismutase in rat lungs after inhalation of inflammatory and fibrogenic minerals. | 1994 Mar |
|
Titanium, chromium and cobalt ions modulate the release of bone-associated cytokines by human monocytes/macrophages in vitro. | 1996 Dec |
|
The effects of particulate wear debris, cytokines, and growth factors on the functions of MG-63 osteoblasts. | 2001 Feb |
|
Molecular and biomechanical characterization of mineralized tissue by dental pulp cells on titanium. | 2005 Jun |
|
Upregulation of LITAF mRNA expression upon exposure to TiAlV and polyethylene wear particles in THP-1 macrophages. | 2007 Apr |
|
Pulmonary exposure to particles during pregnancy causes increased neonatal asthma susceptibility. | 2008 Jan |
|
Differential binding of inorganic particles to MARCO. | 2009 Jan |
|
The effects of implant surface nanoscale features on osteoblast-specific gene expression. | 2009 Sep |
|
The effect of TiO(2) and Ag nanoparticles on reproduction and development of Drosophila melanogaster and CD-1 mice. | 2011 Dec 15 |
|
Toll-like receptors and their adaptors are regulated in macrophages after phagocytosis of lipopolysaccharide-coated titanium particles. | 2011 Jul |
|
Pulmonary instillation of low doses of titanium dioxide nanoparticles in mice leads to particle retention and gene expression changes in the absence of inflammation. | 2013 Jun 15 |
|
Genetic variation influences immune responses in sensitive rats following exposure to TiO2 nanoparticles. | 2014 Dec 4 |
|
Titanium dioxide nanoparticles promote arrhythmias via a direct interaction with rat cardiac tissue. | 2014 Dec 9 |
|
Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells. | 2015 Apr |
|
Genome wide identification and expression profile in epithelial cells exposed to TiO₂ particles. | 2015 Mar |
|
Silver and titanium dioxide nanoparticles alter oxidative/inflammatory response and renin-angiotensin system in brain. | 2015 Nov |
|
TiO2 nanoparticle-induced neurotoxicity may be involved in dysfunction of glutamate metabolism and its receptor expression in mice. | 2016 Jun |
Sample Use Guides
Apply evenly 15 minutes before sun exposure. Reapply as needed or after towel drying, swimming, or perspiring. Children under 6 months of age, ask a doctor.
Route of Administration:
Topical
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/18503414
For the in vitro studies, the stratum corneum side of the skin was in contact with either the aqueous or oily commercial dispersion of microfine TiO2 (150 μl/cm^2). The dermis side was placed onto a tissue of cellulose soaked with isotonic phosphate buffered saline (PBS) of pH 7.4. Twenty-four hours after application of the dispersion, the PBS was removed from the skin with a dry paper towel. For the in vivo studies, 2 μl cm−2 of the commercial dispersions and the different formulations were applied onto the ventral side of the forearm of a healthy female volunteer. After 45 min, any dispersion or formulation that had not penetrated the skin was also removed with a paper towel. All penetration tests were performed in triplicate.
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DSLD |
2074 (Number of products:31)
Created by
admin on Fri Dec 15 16:08:44 GMT 2023 , Edited by admin on Fri Dec 15 16:08:44 GMT 2023
|
||
|
NCI_THESAURUS |
C637
Created by
admin on Fri Dec 15 16:08:44 GMT 2023 , Edited by admin on Fri Dec 15 16:08:44 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB35397
Created by
admin on Fri Dec 15 16:08:44 GMT 2023 , Edited by admin on Fri Dec 15 16:08:44 GMT 2023
|
PRIMARY | |||
|
D1JT611TNE
Created by
admin on Fri Dec 15 16:08:44 GMT 2023 , Edited by admin on Fri Dec 15 16:08:44 GMT 2023
|
PRIMARY | |||
|
m10896
Created by
admin on Fri Dec 15 16:08:44 GMT 2023 , Edited by admin on Fri Dec 15 16:08:44 GMT 2023
|
PRIMARY | Merck Index | ||
|
D1JT611TNE
Created by
admin on Fri Dec 15 16:08:44 GMT 2023 , Edited by admin on Fri Dec 15 16:08:44 GMT 2023
|
PRIMARY | |||
|
DTXSID3047764
Created by
admin on Fri Dec 15 16:08:44 GMT 2023 , Edited by admin on Fri Dec 15 16:08:44 GMT 2023
|
PRIMARY | |||
|
1305547
Created by
admin on Fri Dec 15 16:08:44 GMT 2023 , Edited by admin on Fri Dec 15 16:08:44 GMT 2023
|
PRIMARY | RxNorm | ||
|
7440-32-6
Created by
admin on Fri Dec 15 16:08:44 GMT 2023 , Edited by admin on Fri Dec 15 16:08:44 GMT 2023
|
PRIMARY | |||
|
868
Created by
admin on Fri Dec 15 16:08:44 GMT 2023 , Edited by admin on Fri Dec 15 16:08:44 GMT 2023
|
PRIMARY | |||
|
33341
Created by
admin on Fri Dec 15 16:08:44 GMT 2023 , Edited by admin on Fri Dec 15 16:08:44 GMT 2023
|
PRIMARY | |||
|
231-142-3
Created by
admin on Fri Dec 15 16:08:44 GMT 2023 , Edited by admin on Fri Dec 15 16:08:44 GMT 2023
|
PRIMARY | |||
|
C95189
Created by
admin on Fri Dec 15 16:08:44 GMT 2023 , Edited by admin on Fri Dec 15 16:08:44 GMT 2023
|
PRIMARY | |||
|
DB14160
Created by
admin on Fri Dec 15 16:08:44 GMT 2023 , Edited by admin on Fri Dec 15 16:08:44 GMT 2023
|
PRIMARY | |||
|
23963
Created by
admin on Fri Dec 15 16:08:44 GMT 2023 , Edited by admin on Fri Dec 15 16:08:44 GMT 2023
|
PRIMARY | |||
|
D014025
Created by
admin on Fri Dec 15 16:08:44 GMT 2023 , Edited by admin on Fri Dec 15 16:08:44 GMT 2023
|
PRIMARY |
ACTIVE MOIETY